- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05214625
Questionnaire Study Concerning Artificial Intelligence
Questionnaire Study Concerning Artificial Intelligence and Its Application in (Gastrointestinal) Healthcare - Patients' and Physicians' Perspectives
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.
Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Limburg
-
Maastricht, Limburg, Nederländerna, 6202AZ
- Maastricht University Medical Center
-
-
Noord-Brabant
-
Eindhoven, Noord-Brabant, Nederländerna, 5623 EJ
- Catharina Ziekenhuis Eindhoven
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Gastroenterology patients who will have an outpatient appointment for an endoscopic procedure in the context of the national bowel cancer screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases, in one of two Dutch hospitals between April 2020 and September 2020.
Gastroenterologists and gastroenterology fellows working in Dutch hospitals.
Beskrivning
Inclusion Criteria:
- Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
- Gastroenterologists working in Dutch hospitals;
- Gastroenterology fellows working in Dutch hospitals;
- Minimal age of 18 years old.
Exclusion Criteria:
- No appropriate understanding of the Dutch language;
- Not willing to sign informed consent;
- Objection to participate in medical scientific research, reported in the medical file.
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
Gastroenterology patients
Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered. |
Questionnaire concerning artificial intelligence and its implementation in healthcare.
GI patients and GI physicians will be provided with slightly different questionnaires.
|
Gastroenterology physicians
GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered. |
Questionnaire concerning artificial intelligence and its implementation in healthcare.
GI patients and GI physicians will be provided with slightly different questionnaires.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
The knowledge on AI investigated by means of a questionnaire
Tidsram: 6 months
|
The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
The experience with AI investigated by means of a questionnaire
Tidsram: 6 months
|
The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
The opinion on AI investigated by means of a questionnaire
Tidsram: 6 months
|
The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.
|
6 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Willingness of physicians to use AI in (gastroenterology) healthcare
Tidsram: 6 months
|
The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.
|
6 months
|
Willingness to apply AI in (gastroenterology) healthcare
Tidsram: 6 months
|
The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.
|
6 months
|
Advantages and disadvantages of AI use in (gastroenterology) healthcare
Tidsram: 6 months
|
Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.
|
6 months
|
Potential domains within gastroenterology and hepatology for AI use
Tidsram: 6 months
|
Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.
|
6 months
|
Mandatory infrastructure for AI use in healthcare
Tidsram: 6 months
|
The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.
|
6 months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Ad Masclee, Prof Dr MD, Maastricht Universitair Medisch Centrum
Publikationer och användbara länkar
Allmänna publikationer
- Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Smail-Tabbone M, Danese S, Peyrin-Biroulet L. Application of Artificial Intelligence to Gastroenterology and Hepatology. Gastroenterology. 2020 Jan;158(1):76-94.e2. doi: 10.1053/j.gastro.2019.08.058. Epub 2019 Oct 5.
- Shaban-Nejad A, Michalowski M, Buckeridge DL. Health intelligence: how artificial intelligence transforms population and personalized health. NPJ Digit Med. 2018 Oct 2;1:53. doi: 10.1038/s41746-018-0058-9. eCollection 2018.
- Labovitz DL, Shafner L, Reyes Gil M, Virmani D, Hanina A. Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy. Stroke. 2017 May;48(5):1416-1419. doi: 10.1161/STROKEAHA.116.016281. Epub 2017 Apr 6.
- Waymel Q, Badr S, Demondion X, Cotten A, Jacques T. Impact of the rise of artificial intelligence in radiology: What do radiologists think? Diagn Interv Imaging. 2019 Jun;100(6):327-336. doi: 10.1016/j.diii.2019.03.015. Epub 2019 May 6.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- METC 2020-2281
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Gastrointestinala störningar
-
Jinling Hospital, ChinaAvslutadKronisk intestinal pseudoobstruktionKina
-
BrightseedRekrytering
-
University Hospital TuebingenAvslutadIntestinal graftdysfunktionTyskland
-
Chr HansenAtlantia Food Clinical Trials; Signifikans ApSAvslutad
-
Maastricht University Medical CenterAvslutad
-
a2 Milk Company Ltd.Avslutad
-
University of ReadingAvslutad
-
Christian Medical College and Hospital, Ludhiana...Avslutad
-
Cairo UniversityAvslutadKomplikationer; C, intestinal (intern)Egypten
-
Shanghai Ninth People's Hospital Affiliated to...IndragenMekanisk ventilation | Intestinal mikrobiotaKina